“FIRST-IN-HUMAN” CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN | Zendy

Esther Bernaldo-de-Quirós | Zendy; Manuela Camino | Zendy; JuanMiguel GilJaurena | Zendy; Eugenia Fernández-Santos | Zendy; Nuria Gil | Zendy; Esther Panadero | Zendy; Constancio Medrano | Zendy; Rocío López | Zendy; Marta MartínezBonet | Zendy; Diana Hernández-Flórez | Zendy; Megan K. Levings | Zendy; L. West | Zendy; Marjorie Pion | Zendy; Rafael CorreaRocha | Zendy

Open Access

“FIRST-IN-HUMAN” CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN

Author(s) -

Esther Bernaldo-de-Quirós,

Manuela Camino,

JuanMiguel GilJaurena,

Eugenia Fernández-Santos,

Nuria Gil,

Esther Panadero,

Constancio Medrano,

Rocío López,

Marta MartínezBonet,

Diana Hernández-Flórez,

Megan K. Levings,

L. West,

Marjorie Pion,

Rafael CorreaRocha

Publication year - 2020

Publication title -

transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.45

H-Index - 204

eISSN - 1534-6080

pISSN - 0041-1337

DOI - 10.1097/01.tp.0000698356.92326.e1

Subject(s) - medicine , basiliximab , transplantation , cohort , tacrolimus , heart transplantation , clinical trial , prospective cohort study , immunology , adoptive cell transfer , immune system , t cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog